EmphyCorp
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
84 Park Ave Ste E102, Flemington, New Je...Phone Number
(908) 237-1561Website
www.emphycorp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About EmphyCorp
Emphycorp Inc is a private biotech company based in Flemington, New Jersey, specializing in the development of non-steroidal nasal sprays for the treatment of respiratory diseases, including COVID-19, pulmonary fibrosis, and flu. The company has successfully completed multiple Phase III clinical trials demonstrating the safety and efficacy of its N115 nasal spray, which has no known side effects. With over 70 drug patents worldwide, Emphycorp aims to provide safer alternatives for patients suffering from chronic breathing conditions. Their target clients include individuals with respiratory diseases and COVID-19, as well as healthcare providers seeking effective treatment options.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EmphyCorp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on EmphyCorp recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at EmphyCorp
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when EmphyCorp launches new products
Funding: Get notified immidiatlly once EmphyCorp has new funding data
EmphyCorp, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if EmphyCorp is spiking on competitors!
Click to see if EmphyCorp had a recent Job posting/layoffs
Check if EmphyCorp has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to EmphyCorp
Compare insights from companies similar to EmphyCorp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EmphyCorp
<$5M
1-10
Private
-
1996
N/A
Company Profile Activity
Activity Insights
EmphyCorp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EmphyCorp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EmphyCorp.
EmphyCorp Tech Stack
A closer look at the technologies used by EmphyCorp
See more technologies
EmphyCorp News & Media
EmphyCorp News: As Reported in The Lancet - Clinical Features of Patients Infected with the 2019 novel Coronavirus in Wuhan, China
FLEMINGTON, N.J., March 24, 2020 /PRNewswire/ -- EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, specializes in Rx Non-Steroidal Nasal Spray Technology with no known side effects for all lung diseases. In numerous USA human clinical trials, N115 decreased lung inflammation and...EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
FLEMINGTON, N.J., March 17, 2020 /PRNewswire/ -- EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, is proud to announce that EmphyCorp Rx N115 Non-Steroidal Nasal Spray with no known side effects for Pulmonary Fibrosis, Cystic Fibrosis, COPD, and Unmet Needs COPD significantly...EmphyCorp N115 Rx Globally Patented Non-Steroidal Nasal Spray with No Known Side Effects for Pregnant Women with Allergic Rhinitis or Asthma
FLEMINGTON, N.J., Jan. 21, 2020 /PRNewswire/ -- EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, was proud to announce on January 14th, 2020 the use of its globally patented non-steroidal nasal spray technology for the treatment of all Lung Diseases, with clinical data to support...Rx Globally Patented Non-Steroidal Nasal Spray for All Lung Diseases including Pulmonary Fibrosis, CF, COPD, Unmet Needs with No Known Side Effects that can also be used to Deliver Antivirals, Antimicrobials, Insulin, and other Drugs
EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, was proud to announce on August 12, 2019, the completion of a clinical trial to define medical endpoints as requested by the FDA for the NDA marketing application in patients with Pulmonary Fibrosis, under its Orphan Drug Designations for the treatment of Interstitial Lung Diseases (ILD), and Cystic Fibrosis.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding EmphyCorp
Sign Up For FreeTo access detailed company insights
Emphycorp Inc is a private biotech company based in Flemington, New Jersey, specializing in the development of non-steroidal nasal sprays for the treatment of respiratory diseases, including COVID-19, pulmonary fibrosis, and flu. The company has successfully completed multiple Phase III clinical trials demonstrating the safety and efficacy of its N... Read More
